Delivery Order SPE2DB22D2206-SPE2DB25FDY61

Award Date 10/26/24
Potential Completion Date 10/28/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,216.28 Firm Fixed Price delivery order contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,515.72, is a delivery order for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a respiratory medication. This contract is not designated as a set-aside and will be completed by August 21, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,330.75 firm fixed price delivery order contract is for the supply of Budesonide-Formoterol 80-4.5 10.2 GM, a medical product, with a period of performance through February 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,981.56 Firm Fixed Price Delivery Order contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Budesonide-Formoterol 160-4.5 10.2GM. The $1,894.65 delivery order is a firm fixed-price contract with a completion date of September 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,802.84 firm fixed-price delivery order is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a prescription medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,246.23 Firm Fixed Price delivery order is for the supply of the pharmaceutical product BUDESONIDE-FORMOTEROL 160-4.5 10.2GM. The contract has an ultimate completion date of October 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $1,176.48, is for the delivery of the pharmaceutical product Budesonide-Formoterol 80-4.5 10.2GM. This is a firm fixed price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $5,304.52 firm fixed-price contract is for the supply of the drug Budesonide-Formoterol 80-4.5 10.2GM, with a performance period through June 13, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a global pharmaceutical support vehicle for military and other...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,639.60, is a delivery order for the medical product "BUDESONIDE-FORMOTEROL 160-4.5 10.2GM". The contract has a firm fixed price and an ultimate completion date of January 19, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDY61
    Delivery Order

The federal contract award is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,898.46 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 1/26/25, 12:07 AM